Patents by Inventor Bengt Jeppson

Bengt Jeppson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6287273
    Abstract: A perfusion system for non-surgically isolating and perfusing an organ, particularly the liver (101), in a patient, and including; by-pass cathether apparatus having inlet and outlet lumens (111, 112) introducible into the blood vessels of the organ percutaneously and devised so as to by-pass the blood flow past the organ in a by-pass circuit; perfusion catheter apparatus having inlet and outlet lumens (114, 116) introducible into the blood vessels percutaneously and being devised so as to lead the flow of perfusion fluid in a perfusion circuit through the organ; occlusive seals (106, 108) for isolating the organ from the systemic blood flow; pump apparatus including a by-pass pump (261), a perfusion fluid pump (124) and a suction pump (134) for establishing a negative relative pressure at the perfusion outlet from the organ; and control apparatus (128) coupled to the pumps (124, 126, 134) so as to control the operation thereof such that the outflow of fluid from the organ exceeds the inflow of fluid into the
    Type: Grant
    Filed: July 20, 1999
    Date of Patent: September 11, 2001
    Assignee: Argmed Kommanditbolag
    Inventors: Mats Allers, Krasnodar Ivancev, Bengt Jeppson
  • Patent number: 5591428
    Abstract: A process for isolation of a strain of Lactobacillus having the ability of being established on human intestinal mucosa in vivo and being able to remain therein after oral administration for at least 10 days after the completion of the administration. By the process the new strains L. plantarum 299 (DSM 6595) and L. casei ssp. rhamnosus 271 (DSM 6594) have been isolated, which are useful for the prophylaxis or treatment of bacterial infections, especially in the form of a fermented nutrient composition.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 7, 1997
    Assignee: Probi AB
    Inventors: Stig Bengmark, Siv Ahrne, Goran Molin, Bengt Jeppson
  • Patent number: 5587314
    Abstract: A process for isolation of a strain of Lactobacillus having the ability of being established on human intestinal mucosa in vivo and being able to remain therein after oral administration for at least 10 days after the completion of the administration. By the process the new strains L. plantarum 299 (DSM 6595) and L. casei ssp. rhamnosus 271 (DSM 6594) have been isolated, which are useful for the prophylaxis or treatment of bacterial infections, especially in the form of a fermented nutrient composition.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: December 24, 1996
    Assignee: Probi AB
    Inventors: Stig Bengmark, Siv Ahrne, Goran Molin, Bengt Jeppson
  • Patent number: 5474932
    Abstract: A process for isolation of a strain of Lactobacillus having the ability of being established on human intestinal mucosa in vivo and being able to remain therein after oral administration for at least 10 days after the completion of the administration.By the process the new strains L. plantarum 299 (DSM 6595) and L. casei ssp. rhamnosus 271 (DSM 6594) have been isolated, which are useful for the prophylaxis or treatment of bacterial infections, especially in the form of a fermented nutrient composition.
    Type: Grant
    Filed: April 16, 1993
    Date of Patent: December 12, 1995
    Assignee: Probi AB
    Inventors: Stig Bengmark, Siv Ahrne, Goran Molin, Bengt Jeppson